Xylazine and HIV Retention In Care in the Era of Synthetic Street Drugs

The Pacific AIDS Education and Training Center-Arizona/Nevada, in partnership with the Opioid Response Network, presents a virtual training program that will explain the emergence of xylazine, fentanyl, and crystal methamphetamine in regional markets formerly dominated by heroin and cocaine. It will examine the relationship between each of these newly prevalent synthetic substances and describe what we know about their impact on HIV retention in care and related comorbidities.

Learning objectives:

• Describe how the expansion of xylazine, fentanyl, and crystal methamphetamine use is related to the history of US drug markets since 1990
• Describe how each of these substances relates to one another in the experience of consumption and in their public health impact, including HIV and drug overdose risk
• Examine how xylazine and related transformations to the street drug supply have impacted HIV treatment and prevention, including how it may alter retention in HIV treatment

Thursday, September 4th

12:00 pm – 1:00 pm

Virtual